BCL2A1 and hepatocellular carcinoma: Our findings indicate that the newly identified SPP1+BCL2A1+ TAMs subtype represents a specialized macrophage displaying longevity-related pathways with potential roles in sustaining chronic inflammation, promoting matrix remodeling, and creating a survival-advantaged niche within the microenvironment in HCC, which may display resistance to ICB therapy.